Please login to the form below

Not currently logged in
Email:
Password:

Janssen named ‘Pharma Company of the Year’ at business intelligence awards

Adelphi Research takes home ‘Agency of the year’ trophy

jj

Now celebrating its twelfth year, the Best of Business Intelligence (BOBI) Awards held in London this week named Janssen its ‘Pharma Company of the Year’.

The Johnson & Johnson pharmaceutical subsidiary saw off strong competition from Sanofi, who was also named runner-up in that category.

The awards, which took place at BHBIA’s annual conference on Tuesday, also saw Adelphi Research UK win the ‘Agency of the year’ award, beating rivals CompuFile Systems and HRW.

Another noteworthy winner of the night was Teva’s Chris Reynolds who, along with David Brown from QlickiT, won the ‘Excellence in Business Analytics’ award.

Janssen saw more success after its group project manager, multiple myeloma, Stephen Ireland - along with Research Partnership’s Jennifer Redfearn and Richard Head - picked up an award for ‘Best Business Impact’.

Scooping the ‘Optimising engagement’ award was Adelphi Research UK’s Joanna Thompson, Rachel Medcalf and Francesca Trewartha along with Roche Products’ Glada Soprani, Karl Wilson and Helen Joyce for their work titled ‘Making a Big Noise with the Voice of the Customer’.

The BHBIA also gave IQVIA’s Richard Gray an award for ‘Best Paper at a One-Day Training Course’ after being voted the best overall presenter at a BHBIA training course over the past 12 months.

Article by
Gemma Jones

17th May 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics